Patents by Inventor Chunshan Tang

Chunshan Tang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AROMATIC RING COMPOUND
    Publication number: 20220048939
    Abstract: A novel aromatic ring compound is represented by general formula (I). This compound, isomer, prodrug, solvate, pharmaceutically acceptable salt and pharmaceutical composition thereof are useful in preparing medicaments for treating depression and related symptoms.
    Type: Application
    Filed: April 21, 2020
    Publication date: February 17, 2022
    Inventors: Lin XU, Jianfeng LI, ChunShan TANG, Jingfei HUANG, Chunhong JIANG, Qixin ZHOU
  • Composition comprising ligustroflavone, rhoifolin and hyperin and its pharmaceutical application
    Patent number: 9084807
    Abstract: Disclosed is a composition comprising ligustroflavone, rhoifolin and hyperin, which is prepared according to rational weight ratio: 40% to 80% ligustroflavone, 5% to 45% rhoifolin and 1% to 40% hyperin. The composition can be used as a neuraminidase inhibitor for preventing and treating influenza, and can be formulated into pharmaceutically acceptable dosage forms.
    Type: Grant
    Filed: August 4, 2011
    Date of Patent: July 21, 2015
    Assignees: JIANXI SHANXIANG PHARMACEUTICAL CO. LTD., JIANGXI QINGFENG PHARMACEUTICAL RESEARCH CO., LTD.
    Inventors: Chunshan Tang, Ning Xie, Xiaoling Yang, Wuqing Lv, Zhiyong Li, Jingying Ye, Difa Liu, Fan Cheng
  • Composition Comprising Ligustroflavone, Rhoifolin and Hyperin and Its Pharmaceutical Application
    Publication number: 20130131000
    Abstract: Disclosed is a composition comprising ligustroflavone, rhoifolin and hyperin, which is prepared according to rational weight ratio: 40% to 80% ligustroflavone, 5% to 45% rhoifolin and 1% to 40% hyperin. The composition can be used as a neuraminidase inhibitor for preventing and treating influenza, and can be formulated into pharmaceutically acceptable dosage forms.
    Type: Application
    Filed: August 4, 2011
    Publication date: May 23, 2013
    Applicants: JIANGXI QINGFENG PHARMACEUTICAL RESEARCH CO., LTD., JIANXI SHANXIANG PHARMACEUTICAL CO. LTD.
    Inventors: Chunshan Tang, Ning Xie, Xiaoling Yang, Wuqing Lv, Zhiyong Li, Jingying Ye, Difa Liu, Fan Cheng